Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-09-06 16:15:25
Reporting Period:
Filing Date:
Accepted Time:
2013-09-06 16:15:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1296391 Tengion Inc TNGN Biological Products, (No Disgnostic Substances) (2836) 200214813
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352452 Lorin Randall C/o Tengion, Inc.
3929 Westpoint Blvd., Suite G
Winston-Salem NC 27103
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-14 379 $0.00 379 No 4 C Direct
Common Stock Disposition 2013-09-04 379 $0.63 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Convertible Preferred Stock Disposition 2010-04-14 54,941 $0.00 379 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
  1. On 6/14/12, the Company completed a one-for-ten reverse stock split. The common stock amounts in the filing relating to securities acquired prior to 6/14/12 have been adjusted to reflect the one-for-ten reverse stock split.
  2. These securities are Preferred Stock of the Issuer and do not have an expiration date. These securities automatically converted into common stock of the Issuer on a 14.5-for-one basis upon the closing of the Issuer's initial public offering of common stock.